Switch theme
Sign up to access all valuation multiples
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, neurosurgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
2016
2.7K+
LTM Revenue $408M
LTM EBITDA $122M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Akdital has a last 12-month revenue (LTM) of $408M and a last 12-month EBITDA of $122M.
In the most recent fiscal year, Akdital achieved revenue of $330M and an EBITDA of $93.9M.
Akdital expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Akdital valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $408M | XXX | $330M | XXX | XXX | XXX |
| Gross Profit | $260M | XXX | $167M | XXX | XXX | XXX |
| Gross Margin | 64% | XXX | 51% | XXX | XXX | XXX |
| EBITDA | $122M | XXX | $93.9M | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 28% | XXX | XXX | XXX |
| EBIT | $78.2M | XXX | $58.0M | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 18% | XXX | XXX | XXX |
| Net Profit | $47.7M | XXX | $35.1M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Akdital's stock price is MAD n/a (or $n/a).
Akdital has current market cap of MAD 13.3B (or $1.5B), and EV of MAD 14.2B (or $1.6B).
See Akdital trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $1.5B | XXX | XXX | XXX | XXX | $3.66 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Akdital has market cap of $1.5B and EV of $1.6B.
Akdital's trades at 4.8x EV/Revenue multiple, and 16.9x EV/EBITDA.
Equity research analysts estimate Akdital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Akdital has a P/E ratio of 31.2x.
See valuation multiples for Akdital and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 3.9x | XXX | 4.8x | XXX | XXX | XXX |
| EV/EBITDA | 13.1x | XXX | 16.9x | XXX | XXX | XXX |
| EV/EBIT | 20.3x | XXX | 27.4x | XXX | XXX | XXX |
| EV/Gross Profit | 6.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 31.2x | XXX | 42.4x | XXX | XXX | XXX |
| EV/FCF | -7.9x | XXX | -5.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAkdital's last 12 month revenue growth is 47%
Akdital's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $41K for the same period.
Akdital's rule of 40 is 75% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Akdital's rule of X is 146% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Akdital and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 47% | XXX | 47% | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | 52% | XXX | 62% | XXX | XXX | XXX |
| Rule of 40 | 75% | XXX | 75% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 146% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $41K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Akdital acquired XXX companies to date.
Last acquisition by Akdital was XXXXXXXX, XXXXX XXXXX XXXXXX . Akdital acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Akdital founded? | Akdital was founded in 2016. |
| Where is Akdital headquartered? | Akdital is headquartered in Morocco. |
| How many employees does Akdital have? | As of today, Akdital has 2.7K+ employees. |
| Is Akdital publicy listed? | Yes, Akdital is a public company listed on CAS. |
| What is the stock symbol of Akdital? | Akdital trades under AKT ticker. |
| When did Akdital go public? | Akdital went public in 2022. |
| Who are competitors of Akdital? | Similar companies to Akdital include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Akdital? | Akdital's current market cap is $1.5B |
| What is the current revenue of Akdital? | Akdital's last 12 months revenue is $408M. |
| What is the current revenue growth of Akdital? | Akdital revenue growth (NTM/LTM) is 47%. |
| What is the current EV/Revenue multiple of Akdital? | Current revenue multiple of Akdital is 3.9x. |
| Is Akdital profitable? | Yes, Akdital is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Akdital? | Akdital's last 12 months EBITDA is $122M. |
| What is Akdital's EBITDA margin? | Akdital's last 12 months EBITDA margin is 30%. |
| What is the current EV/EBITDA multiple of Akdital? | Current EBITDA multiple of Akdital is 13.1x. |
| What is the current FCF of Akdital? | Akdital's last 12 months FCF is -$202M. |
| What is Akdital's FCF margin? | Akdital's last 12 months FCF margin is -50%. |
| What is the current EV/FCF multiple of Akdital? | Current FCF multiple of Akdital is -7.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
